A large number of experiments in biomedical research are carried out on tissues, but, even though the results should be applicable to humans, these tissues are mainly of animal origin. The difficulty encountered in obtaining human organs and tissues is an acknowledged problem: not enough human tissues are available to meet research needs. We are introducing the ATRA Project, with the purpose of supporting progress in biomedical research in Switzerland through the establishment of one or more human tissue banks, which will be able to find, treat, preserve and supply human material. Where similar projects have already been launched, concerns have been expressed that donation for research purposes might compete with donation for transplantation, but most organs and tissues are in any case non-transplantable. Surplus surgical tissue is considered “sanitary waste”, and must be treated according to specific regulations for collection, packaging, transport, treatment and disposal. A human tissue bank would not only abate the costs of treating sanitary waste, but would actually turn what is now considered waste into a resource which could be used to save human and animal lives.
BachP.H., VickersA.E.M., FisherR., BaumannA., BritteboE., CarlileD.J., KosterH.J., LakeB.G., SalmonF., SawyerT.W., & SkibinskiG. (1996). The use of tissue slices for pharmacotoxicology studies. The report and recommendations of ECVAM workshop 20. ATLA24, 893–923.
2.
BaderA., KnopE., KernA., BokerK., FruhaufN., GomeO., EsselmannH., PapeC., KempkaG., & SewingK. (1996). 3-D coculture of hepatic sinusoidal cells with primary hepatocytes: design of an organotypical model. Experimental Cell Research226, 223–233.
3.
WardS.L., WalkerT.L., & DimitrijevichS.D. (1997). Evaluation of chemically induced toxicity using an in vitro model of human corneal epithelium. Toxicology in Vitro11, 121–139.
4.
WardR.K., HubbardA.W., SulleyH., GarleM.J., & ClothierR.H. (1998). Human keratinocyte cultures in an in vitro approach for the assessment of surfactant-induced irritation. Toxicology in Vitro12, 163–173.
5.
HawksworthG.M. (1994). Advantages and disadvantages of using human cells for pharmacological and toxicological studies. Human and Experimental Toxicology13, 568–573.
6.
OrrS., AlexandreE., ClarkB., CombesR., FelsL.M., GrayN., Jönsson-RylanderA.C., HelinH., KoistinenJ., OinonenT., RichertL., RavidR., SalonenJ., TeesaluT., ThaslerW., TraffordJ., van der ValkJ., von VersenR., WeissT., WomackC., & YlikomiT. (2002). The establishment of a network of European human research tissue banks. Cell and Tissue Banking3, 133–137.
7.
AAVV (1993). Human Cells in In Vitro Pharmacotoxicology. Present Status within Europe (ed. RogiersV., SonckW., ShephardE., & VercruysseA.), 328 pp. Brussels, Belgium: VUB Press.
8.
StartR.D., BrownW., BryantR.J., ReedM.W., CrossS.S., KentG., & UnderwoodJ.C.E. (1996). Ownership and uses of human tissue: does the Nuffield bioethics report accord with opinion of surgical inpatients?British Medical Journal313, 1366–1368.
9.
GurneyJ., & BallsM. (1993). Obtaining human tissues for research and testing: practical problems and public attitudes in Britain. In Human Cells in In Vitro Pharmacotoxicology. Present Status within Europe (ed. RogiersV., SonckW., ShephardE., & VercruysseA.), pp. 315–328. Brussels, Belgium: VUB Press.
10.
SkettP., TysonC., GuillouzoA., & MaierP. (1995). Report on the international workshop on the use of human in vitro liver preparations to study drug metabolism in drug development, held at Utrecht, The Netherlands, 6–8 September 1994. Biochemical Pharmacology50, 280–285.
11.
The Nuffield Council on Bioethics (1995). Human Tissue: Ethical and Legal Issues, 155 pp. London, UK: Nuffield Council on Bioethics.
12.
FentemJ.H. (1994). The use of human tissues in toxicology: the use of human tissues in in vitro toxicology, Sterling 28/29 April 1993, summary of general discussions. Human and Experimental Toxicology13, 445–449.
13.
AndersonR., O'HareM., BallsM., BradyM., BrahamsD., BurtA., ChesneC., CombesR., DennisonA., GarthoffB., HawksworthG., KalterE., LechatA., MayerD., RogiersV., SladowskiD., SoutheeJ., TraffordJ., van der ValkJ., & van ZellerA-M. (1998). The availability of human tissue for biomedical research. The report and recommendations of ECVAM workshop 32. ATLA26, 763–777.
14.
Anon. (2003). Tierversuche in der Schweiz, 8 pp. Bern, Switzerland: BVET.
15.
European Commission (2003). Third Report from the Commission to the Council and the European Parliament on the Statistics on the Number of Animals Used for Experimental and Other Scientific Purposes in the Member States of the European Union, 175 pp. Brussels, Belgium: European Commission. Website http://europa.eu.int/eur-lex/en/com/rpt/2003/com2003_0019en01.pdf.
16.
LloydT.D.R., OrrS., & DennisonA.R. (2003). A survey of consumer attitudes to the supply and use of human hepatocytes in the United Kingdom. ATLA31, 483–488.
17.
AndersonR., BallsM., BurkeM.D., CumminsM., FehilyD., GrayN., GrootG.M., HelinH., HuntC., JonesD., PriceD., RichertL., RavidR., ShuteD., SladowskiD., StoneH., ThaslerW., TraffordJ., van der ValkJ., WeissT., WomackC., & YlikomiT. (2001). The establishment of human research tissue banking in the UK and several Western European countries. The report and recommendations of ECVAM workshop 44. ATLA29, 125–134.
18.
Anon. (1961). Human Tissue Act, 2 pp. London, UK: HMSO.
19.
Anon. (2003). Federal Law on Environment Safety, 812-01, LPAmb, 42 pp. Bern, Switzerland: Swiss Confederation.
20.
Anon. (2001). Federal Law on Organ, Tissue and Cell Transplantation, 2001-0918, 10 pp. Bern, Switzerland: Swiss Confederation.
21.
Anon. (2003). Federal Law on Animal Protection, RS 455, LPDA, 12 pp. Bern, Switzerland: Swiss Confederation.
Anon. (1989). The Human Organ Transplant Act, 8 pp. London, UK: HMSO.
24.
ChesneC., GuyomardC., FautrelA., PoullainM.G., FremondB., de JongH., & GuillouzoA. (1993). Viability and function in primary culture of adult hepatocytes from various animal species and human beings after preservation. Hepatology18, 406–416.
25.
GuillouzoA., & Guguen-GuillouzoC. (1992). In vitro approaches to hepatotoxicity studies. In In Vitro Methods in Toxicology (ed. JollesG., & CordierA.), pp. 133–163. London, UK: Academic Press.
26.
HirelB., ChesneC., PailheretJ.P., & GuillouzoA. (1994). Expression of differentiation markers in human adult keratinocytes cultured in submerged conditions. In Vitro Cellular and Developmental Biology — Animal30, 372–378.
27.
DonM., de SousaG., LacarelleB., PlacidiM., Lechene de la PorteP., DomingoM., LafontH., & RahmaniR. (1992). Thawed human hepatocytes in primary culture. Cryobiology29, 454–469.
28.
NHS Executive (1996). Guidance on the Microbiological Safety of Human Tissues and Organs Used in Transplantation, 55 pp. London, UK: NHS Executive.
29.
MorganR., ed. (1997). Managing Biological and Chemical Risk, 230 pp. London, UK: Institute of Biology.
